During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Phillip H. Phan, PhD
Advertisement
Articles by Phillip H. Phan, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eli Lilly to acquire Adverum Biotechnologies
2
Regeneron receives another CRL for its Eylea 8 mg
3
Anti-VEGF innovations in retinal disease: From molecules to medicine
4
SparingVision doses first patient in NYRVANA clinical trial of SPVN20 for retinitis pigmentosa
5
.png "Optometry Times"){kind=logo}
